CNCR
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
CNCR
Delisted
CNCR was delisted on the 27th of May, 2025.
10 hedge funds and large institutions have $2.89M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2016 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 1 closing their positions.
Holders
10
Holders Change
-1
Holders Change %
-9.09%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
3
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$1.25M |
2 |
2
Royal Bank of Canada
Toronto,
Ontario, Canada
|
$353K |
3 |
LTFS
3
Ladenburg Thalmann Financial Services
Miami,
Florida
|
$27K |
Top Sellers
1 |
1
Jane Street
New York
|
$275K |
2 |
2
LPL Financial
San Diego,
California
|
$934K |
3 |
TRCT
3
Tower Research Capital (TRC)
New York
|
$0 |